Global Mirabegron Sustained Release Tablets Market Research Report 2026(Status and Outlook)
Mirabegron sustained-release tablets are designed to provide a controlled release of the medication over an extended period, which helps maintain stable levels of mirabegron in the bloodstream.This formulation is used to treat overactive bladder (OAB) symptoms, including frequent urination, urgency, and urinary incontinence.
The global Mirabegron Sustained Release Tablets market size was estimated at USD 2350.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Mirabegron Sustained Release Tablets market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Mirabegron Sustained Release Tablets market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Mirabegron Sustained Release Tablets market.
Global Mirabegron Sustained Release Tablets Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Astellas Pharma
Zydus Lifesciences
Lupin Pharmaceuticals
Alkem Laboratories
Chia Tai Tianqing Pharmaceutical
Zhejiang Huayi Pharmaceutical
China Resources Pharmaceutical
Jiangxi Shanxiang Pharmaceutical
CSPC Pharmaceutical
Qilu Pharmaceutical
Jiangsu Huayang Pharmaceutical
Sichuan Gowell Pharmaceutical
Shenzhen Main Luck Pharmaceuticals
Market Segmentation (by Type)
25mg per Tablet
50mg per Tablet
Market Segmentation (by Application)
Hospital and Clinic
Pharmacy
Other
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Mirabegron Sustained Release Tablets Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Mirabegron Sustained Release Tablets, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Mirabegron Sustained Release Tablets market size was estimated at USD 2350.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Mirabegron Sustained Release Tablets market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Mirabegron Sustained Release Tablets market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Mirabegron Sustained Release Tablets market.
Global Mirabegron Sustained Release Tablets Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Astellas Pharma
Zydus Lifesciences
Lupin Pharmaceuticals
Alkem Laboratories
Chia Tai Tianqing Pharmaceutical
Zhejiang Huayi Pharmaceutical
China Resources Pharmaceutical
Jiangxi Shanxiang Pharmaceutical
CSPC Pharmaceutical
Qilu Pharmaceutical
Jiangsu Huayang Pharmaceutical
Sichuan Gowell Pharmaceutical
Shenzhen Main Luck Pharmaceuticals
Market Segmentation (by Type)
25mg per Tablet
50mg per Tablet
Market Segmentation (by Application)
Hospital and Clinic
Pharmacy
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Mirabegron Sustained Release Tablets Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Mirabegron Sustained Release Tablets Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Mirabegron Sustained Release Tablets, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Mirabegron Sustained Release Tablets
1.2 Key Market Segments
1.2.1 Mirabegron Sustained Release Tablets Segment by Type
1.2.2 Mirabegron Sustained Release Tablets Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Mirabegron Sustained Release Tablets Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Mirabegron Sustained Release Tablets Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Mirabegron Sustained Release Tablets Product Life Cycle
3.3 Global Mirabegron Sustained Release Tablets Sales by Manufacturers (2020-2025)
3.4 Global Mirabegron Sustained Release Tablets Revenue Market Share by Manufacturers (2020-2025)
3.5 Mirabegron Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Mirabegron Sustained Release Tablets Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Mirabegron Sustained Release Tablets Market Competitive Situation and Trends
3.8.1 Mirabegron Sustained Release Tablets Market Concentration Rate
3.8.2 Global 5 and 10 Largest Mirabegron Sustained Release Tablets Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MIRABEGRON SUSTAINED RELEASE TABLETS INDUSTRY CHAIN ANALYSIS
4.1 Mirabegron Sustained Release Tablets Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MIRABEGRON SUSTAINED RELEASE TABLETS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Mirabegron Sustained Release Tablets Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Mirabegron Sustained Release Tablets Market
5.7 ESG Ratings of Leading Companies
6 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Mirabegron Sustained Release Tablets Sales Market Share by Type (2020-2025)
6.3 Global Mirabegron Sustained Release Tablets Market Size by Type (2020-2025)
6.4 Global Mirabegron Sustained Release Tablets Price by Type (2020-2025)
7 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Mirabegron Sustained Release Tablets Market Sales by Application (2020-2025)
7.3 Global Mirabegron Sustained Release Tablets Market Size (M USD) by Application (2020-2025)
7.4 Global Mirabegron Sustained Release Tablets Sales Growth Rate by Application (2020-2025)
8 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET SALES BY REGION
8.1 Global Mirabegron Sustained Release Tablets Sales by Region
8.1.1 Global Mirabegron Sustained Release Tablets Sales by Region
8.1.2 Global Mirabegron Sustained Release Tablets Sales Market Share by Region
8.2 Global Mirabegron Sustained Release Tablets Market Size by Region
8.2.1 Global Mirabegron Sustained Release Tablets Market Size by Region
8.2.2 Global Mirabegron Sustained Release Tablets Market Size by Region
8.3 North America
8.3.1 North America Mirabegron Sustained Release Tablets Sales by Country
8.3.2 North America Mirabegron Sustained Release Tablets Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Mirabegron Sustained Release Tablets Sales by Country
8.4.2 Europe Mirabegron Sustained Release Tablets Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Mirabegron Sustained Release Tablets Sales by Region
8.5.2 Asia Pacific Mirabegron Sustained Release Tablets Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Mirabegron Sustained Release Tablets Sales by Country
8.6.2 South America Mirabegron Sustained Release Tablets Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Mirabegron Sustained Release Tablets Sales by Region
8.7.2 Middle East and Africa Mirabegron Sustained Release Tablets Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET PRODUCTION BY REGION
9.1 Global Production of Mirabegron Sustained Release Tablets by Region(2020-2025)
9.2 Global Mirabegron Sustained Release Tablets Revenue Market Share by Region (2020-2025)
9.3 Global Mirabegron Sustained Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Mirabegron Sustained Release Tablets Production
9.4.1 North America Mirabegron Sustained Release Tablets Production Growth Rate (2020-2025)
9.4.2 North America Mirabegron Sustained Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Mirabegron Sustained Release Tablets Production
9.5.1 Europe Mirabegron Sustained Release Tablets Production Growth Rate (2020-2025)
9.5.2 Europe Mirabegron Sustained Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Mirabegron Sustained Release Tablets Production (2020-2025)
9.6.1 Japan Mirabegron Sustained Release Tablets Production Growth Rate (2020-2025)
9.6.2 Japan Mirabegron Sustained Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Mirabegron Sustained Release Tablets Production (2020-2025)
9.7.1 China Mirabegron Sustained Release Tablets Production Growth Rate (2020-2025)
9.7.2 China Mirabegron Sustained Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Astellas Pharma
10.1.1 Astellas Pharma Basic Information
10.1.2 Astellas Pharma Mirabegron Sustained Release Tablets Product Overview
10.1.3 Astellas Pharma Mirabegron Sustained Release Tablets Product Market Performance
10.1.4 Astellas Pharma Business Overview
10.1.5 Astellas Pharma SWOT Analysis
10.1.6 Astellas Pharma Recent Developments
10.2 Zydus Lifesciences
10.2.1 Zydus Lifesciences Basic Information
10.2.2 Zydus Lifesciences Mirabegron Sustained Release Tablets Product Overview
10.2.3 Zydus Lifesciences Mirabegron Sustained Release Tablets Product Market Performance
10.2.4 Zydus Lifesciences Business Overview
10.2.5 Zydus Lifesciences SWOT Analysis
10.2.6 Zydus Lifesciences Recent Developments
10.3 Lupin Pharmaceuticals
10.3.1 Lupin Pharmaceuticals Basic Information
10.3.2 Lupin Pharmaceuticals Mirabegron Sustained Release Tablets Product Overview
10.3.3 Lupin Pharmaceuticals Mirabegron Sustained Release Tablets Product Market Performance
10.3.4 Lupin Pharmaceuticals Business Overview
10.3.5 Lupin Pharmaceuticals SWOT Analysis
10.3.6 Lupin Pharmaceuticals Recent Developments
10.4 Alkem Laboratories
10.4.1 Alkem Laboratories Basic Information
10.4.2 Alkem Laboratories Mirabegron Sustained Release Tablets Product Overview
10.4.3 Alkem Laboratories Mirabegron Sustained Release Tablets Product Market Performance
10.4.4 Alkem Laboratories Business Overview
10.4.5 Alkem Laboratories Recent Developments
10.5 Chia Tai Tianqing Pharmaceutical
10.5.1 Chia Tai Tianqing Pharmaceutical Basic Information
10.5.2 Chia Tai Tianqing Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.5.3 Chia Tai Tianqing Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.5.4 Chia Tai Tianqing Pharmaceutical Business Overview
10.5.5 Chia Tai Tianqing Pharmaceutical Recent Developments
10.6 Zhejiang Huayi Pharmaceutical
10.6.1 Zhejiang Huayi Pharmaceutical Basic Information
10.6.2 Zhejiang Huayi Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.6.3 Zhejiang Huayi Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.6.4 Zhejiang Huayi Pharmaceutical Business Overview
10.6.5 Zhejiang Huayi Pharmaceutical Recent Developments
10.7 China Resources Pharmaceutical
10.7.1 China Resources Pharmaceutical Basic Information
10.7.2 China Resources Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.7.3 China Resources Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.7.4 China Resources Pharmaceutical Business Overview
10.7.5 China Resources Pharmaceutical Recent Developments
10.8 Jiangxi Shanxiang Pharmaceutical
10.8.1 Jiangxi Shanxiang Pharmaceutical Basic Information
10.8.2 Jiangxi Shanxiang Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.8.3 Jiangxi Shanxiang Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.8.4 Jiangxi Shanxiang Pharmaceutical Business Overview
10.8.5 Jiangxi Shanxiang Pharmaceutical Recent Developments
10.9 CSPC Pharmaceutical
10.9.1 CSPC Pharmaceutical Basic Information
10.9.2 CSPC Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.9.3 CSPC Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.9.4 CSPC Pharmaceutical Business Overview
10.9.5 CSPC Pharmaceutical Recent Developments
10.10 Qilu Pharmaceutical
10.10.1 Qilu Pharmaceutical Basic Information
10.10.2 Qilu Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.10.3 Qilu Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.10.4 Qilu Pharmaceutical Business Overview
10.10.5 Qilu Pharmaceutical Recent Developments
10.11 Jiangsu Huayang Pharmaceutical
10.11.1 Jiangsu Huayang Pharmaceutical Basic Information
10.11.2 Jiangsu Huayang Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.11.3 Jiangsu Huayang Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.11.4 Jiangsu Huayang Pharmaceutical Business Overview
10.11.5 Jiangsu Huayang Pharmaceutical Recent Developments
10.12 Sichuan Gowell Pharmaceutical
10.12.1 Sichuan Gowell Pharmaceutical Basic Information
10.12.2 Sichuan Gowell Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.12.3 Sichuan Gowell Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.12.4 Sichuan Gowell Pharmaceutical Business Overview
10.12.5 Sichuan Gowell Pharmaceutical Recent Developments
10.13 Shenzhen Main Luck Pharmaceuticals
10.13.1 Shenzhen Main Luck Pharmaceuticals Basic Information
10.13.2 Shenzhen Main Luck Pharmaceuticals Mirabegron Sustained Release Tablets Product Overview
10.13.3 Shenzhen Main Luck Pharmaceuticals Mirabegron Sustained Release Tablets Product Market Performance
10.13.4 Shenzhen Main Luck Pharmaceuticals Business Overview
10.13.5 Shenzhen Main Luck Pharmaceuticals Recent Developments
11 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET FORECAST BY REGION
11.1 Global Mirabegron Sustained Release Tablets Market Size Forecast
11.2 Global Mirabegron Sustained Release Tablets Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Mirabegron Sustained Release Tablets Market Size Forecast by Country
11.2.3 Asia Pacific Mirabegron Sustained Release Tablets Market Size Forecast by Region
11.2.4 South America Mirabegron Sustained Release Tablets Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Mirabegron Sustained Release Tablets by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Mirabegron Sustained Release Tablets Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Mirabegron Sustained Release Tablets by Type (2026-2035)
12.1.2 Global Mirabegron Sustained Release Tablets Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Mirabegron Sustained Release Tablets by Type (2026-2035)
12.2 Global Mirabegron Sustained Release Tablets Market Forecast by Application (2026-2035)
12.2.1 Global Mirabegron Sustained Release Tablets Sales (K MT) Forecast by Application
12.2.2 Global Mirabegron Sustained Release Tablets Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Mirabegron Sustained Release Tablets
1.2 Key Market Segments
1.2.1 Mirabegron Sustained Release Tablets Segment by Type
1.2.2 Mirabegron Sustained Release Tablets Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Mirabegron Sustained Release Tablets Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Mirabegron Sustained Release Tablets Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Mirabegron Sustained Release Tablets Product Life Cycle
3.3 Global Mirabegron Sustained Release Tablets Sales by Manufacturers (2020-2025)
3.4 Global Mirabegron Sustained Release Tablets Revenue Market Share by Manufacturers (2020-2025)
3.5 Mirabegron Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Mirabegron Sustained Release Tablets Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Mirabegron Sustained Release Tablets Market Competitive Situation and Trends
3.8.1 Mirabegron Sustained Release Tablets Market Concentration Rate
3.8.2 Global 5 and 10 Largest Mirabegron Sustained Release Tablets Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MIRABEGRON SUSTAINED RELEASE TABLETS INDUSTRY CHAIN ANALYSIS
4.1 Mirabegron Sustained Release Tablets Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MIRABEGRON SUSTAINED RELEASE TABLETS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Mirabegron Sustained Release Tablets Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Mirabegron Sustained Release Tablets Market
5.7 ESG Ratings of Leading Companies
6 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Mirabegron Sustained Release Tablets Sales Market Share by Type (2020-2025)
6.3 Global Mirabegron Sustained Release Tablets Market Size by Type (2020-2025)
6.4 Global Mirabegron Sustained Release Tablets Price by Type (2020-2025)
7 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Mirabegron Sustained Release Tablets Market Sales by Application (2020-2025)
7.3 Global Mirabegron Sustained Release Tablets Market Size (M USD) by Application (2020-2025)
7.4 Global Mirabegron Sustained Release Tablets Sales Growth Rate by Application (2020-2025)
8 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET SALES BY REGION
8.1 Global Mirabegron Sustained Release Tablets Sales by Region
8.1.1 Global Mirabegron Sustained Release Tablets Sales by Region
8.1.2 Global Mirabegron Sustained Release Tablets Sales Market Share by Region
8.2 Global Mirabegron Sustained Release Tablets Market Size by Region
8.2.1 Global Mirabegron Sustained Release Tablets Market Size by Region
8.2.2 Global Mirabegron Sustained Release Tablets Market Size by Region
8.3 North America
8.3.1 North America Mirabegron Sustained Release Tablets Sales by Country
8.3.2 North America Mirabegron Sustained Release Tablets Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Mirabegron Sustained Release Tablets Sales by Country
8.4.2 Europe Mirabegron Sustained Release Tablets Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Mirabegron Sustained Release Tablets Sales by Region
8.5.2 Asia Pacific Mirabegron Sustained Release Tablets Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Mirabegron Sustained Release Tablets Sales by Country
8.6.2 South America Mirabegron Sustained Release Tablets Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Mirabegron Sustained Release Tablets Sales by Region
8.7.2 Middle East and Africa Mirabegron Sustained Release Tablets Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET PRODUCTION BY REGION
9.1 Global Production of Mirabegron Sustained Release Tablets by Region(2020-2025)
9.2 Global Mirabegron Sustained Release Tablets Revenue Market Share by Region (2020-2025)
9.3 Global Mirabegron Sustained Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Mirabegron Sustained Release Tablets Production
9.4.1 North America Mirabegron Sustained Release Tablets Production Growth Rate (2020-2025)
9.4.2 North America Mirabegron Sustained Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Mirabegron Sustained Release Tablets Production
9.5.1 Europe Mirabegron Sustained Release Tablets Production Growth Rate (2020-2025)
9.5.2 Europe Mirabegron Sustained Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Mirabegron Sustained Release Tablets Production (2020-2025)
9.6.1 Japan Mirabegron Sustained Release Tablets Production Growth Rate (2020-2025)
9.6.2 Japan Mirabegron Sustained Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Mirabegron Sustained Release Tablets Production (2020-2025)
9.7.1 China Mirabegron Sustained Release Tablets Production Growth Rate (2020-2025)
9.7.2 China Mirabegron Sustained Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Astellas Pharma
10.1.1 Astellas Pharma Basic Information
10.1.2 Astellas Pharma Mirabegron Sustained Release Tablets Product Overview
10.1.3 Astellas Pharma Mirabegron Sustained Release Tablets Product Market Performance
10.1.4 Astellas Pharma Business Overview
10.1.5 Astellas Pharma SWOT Analysis
10.1.6 Astellas Pharma Recent Developments
10.2 Zydus Lifesciences
10.2.1 Zydus Lifesciences Basic Information
10.2.2 Zydus Lifesciences Mirabegron Sustained Release Tablets Product Overview
10.2.3 Zydus Lifesciences Mirabegron Sustained Release Tablets Product Market Performance
10.2.4 Zydus Lifesciences Business Overview
10.2.5 Zydus Lifesciences SWOT Analysis
10.2.6 Zydus Lifesciences Recent Developments
10.3 Lupin Pharmaceuticals
10.3.1 Lupin Pharmaceuticals Basic Information
10.3.2 Lupin Pharmaceuticals Mirabegron Sustained Release Tablets Product Overview
10.3.3 Lupin Pharmaceuticals Mirabegron Sustained Release Tablets Product Market Performance
10.3.4 Lupin Pharmaceuticals Business Overview
10.3.5 Lupin Pharmaceuticals SWOT Analysis
10.3.6 Lupin Pharmaceuticals Recent Developments
10.4 Alkem Laboratories
10.4.1 Alkem Laboratories Basic Information
10.4.2 Alkem Laboratories Mirabegron Sustained Release Tablets Product Overview
10.4.3 Alkem Laboratories Mirabegron Sustained Release Tablets Product Market Performance
10.4.4 Alkem Laboratories Business Overview
10.4.5 Alkem Laboratories Recent Developments
10.5 Chia Tai Tianqing Pharmaceutical
10.5.1 Chia Tai Tianqing Pharmaceutical Basic Information
10.5.2 Chia Tai Tianqing Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.5.3 Chia Tai Tianqing Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.5.4 Chia Tai Tianqing Pharmaceutical Business Overview
10.5.5 Chia Tai Tianqing Pharmaceutical Recent Developments
10.6 Zhejiang Huayi Pharmaceutical
10.6.1 Zhejiang Huayi Pharmaceutical Basic Information
10.6.2 Zhejiang Huayi Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.6.3 Zhejiang Huayi Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.6.4 Zhejiang Huayi Pharmaceutical Business Overview
10.6.5 Zhejiang Huayi Pharmaceutical Recent Developments
10.7 China Resources Pharmaceutical
10.7.1 China Resources Pharmaceutical Basic Information
10.7.2 China Resources Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.7.3 China Resources Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.7.4 China Resources Pharmaceutical Business Overview
10.7.5 China Resources Pharmaceutical Recent Developments
10.8 Jiangxi Shanxiang Pharmaceutical
10.8.1 Jiangxi Shanxiang Pharmaceutical Basic Information
10.8.2 Jiangxi Shanxiang Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.8.3 Jiangxi Shanxiang Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.8.4 Jiangxi Shanxiang Pharmaceutical Business Overview
10.8.5 Jiangxi Shanxiang Pharmaceutical Recent Developments
10.9 CSPC Pharmaceutical
10.9.1 CSPC Pharmaceutical Basic Information
10.9.2 CSPC Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.9.3 CSPC Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.9.4 CSPC Pharmaceutical Business Overview
10.9.5 CSPC Pharmaceutical Recent Developments
10.10 Qilu Pharmaceutical
10.10.1 Qilu Pharmaceutical Basic Information
10.10.2 Qilu Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.10.3 Qilu Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.10.4 Qilu Pharmaceutical Business Overview
10.10.5 Qilu Pharmaceutical Recent Developments
10.11 Jiangsu Huayang Pharmaceutical
10.11.1 Jiangsu Huayang Pharmaceutical Basic Information
10.11.2 Jiangsu Huayang Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.11.3 Jiangsu Huayang Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.11.4 Jiangsu Huayang Pharmaceutical Business Overview
10.11.5 Jiangsu Huayang Pharmaceutical Recent Developments
10.12 Sichuan Gowell Pharmaceutical
10.12.1 Sichuan Gowell Pharmaceutical Basic Information
10.12.2 Sichuan Gowell Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
10.12.3 Sichuan Gowell Pharmaceutical Mirabegron Sustained Release Tablets Product Market Performance
10.12.4 Sichuan Gowell Pharmaceutical Business Overview
10.12.5 Sichuan Gowell Pharmaceutical Recent Developments
10.13 Shenzhen Main Luck Pharmaceuticals
10.13.1 Shenzhen Main Luck Pharmaceuticals Basic Information
10.13.2 Shenzhen Main Luck Pharmaceuticals Mirabegron Sustained Release Tablets Product Overview
10.13.3 Shenzhen Main Luck Pharmaceuticals Mirabegron Sustained Release Tablets Product Market Performance
10.13.4 Shenzhen Main Luck Pharmaceuticals Business Overview
10.13.5 Shenzhen Main Luck Pharmaceuticals Recent Developments
11 MIRABEGRON SUSTAINED RELEASE TABLETS MARKET FORECAST BY REGION
11.1 Global Mirabegron Sustained Release Tablets Market Size Forecast
11.2 Global Mirabegron Sustained Release Tablets Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Mirabegron Sustained Release Tablets Market Size Forecast by Country
11.2.3 Asia Pacific Mirabegron Sustained Release Tablets Market Size Forecast by Region
11.2.4 South America Mirabegron Sustained Release Tablets Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Mirabegron Sustained Release Tablets by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Mirabegron Sustained Release Tablets Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Mirabegron Sustained Release Tablets by Type (2026-2035)
12.1.2 Global Mirabegron Sustained Release Tablets Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Mirabegron Sustained Release Tablets by Type (2026-2035)
12.2 Global Mirabegron Sustained Release Tablets Market Forecast by Application (2026-2035)
12.2.1 Global Mirabegron Sustained Release Tablets Sales (K MT) Forecast by Application
12.2.2 Global Mirabegron Sustained Release Tablets Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Mirabegron Sustained Release Tablets Market Size by Type (M USD)
Table 4. Global Mirabegron Sustained Release Tablets Market Size by Application
Table 5. Mirabegron Sustained Release Tablets Market Size Comparison by Region (M USD)
Table 6. Global Mirabegron Sustained Release Tablets Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Mirabegron Sustained Release Tablets Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Mirabegron Sustained Release Tablets Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Mirabegron Sustained Release Tablets Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mirabegron Sustained Release Tablets as of 2025)
Table 11. Global Market Mirabegron Sustained Release Tablets Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Mirabegron Sustained Release Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Mirabegron Sustained Release Tablets Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Mirabegron Sustained Release Tablets Sales by Type (K MT)
Table 27. Global Mirabegron Sustained Release Tablets Market Size by Type (M USD)
Table 28. Global Mirabegron Sustained Release Tablets Sales (K MT) by Type (2020-2025)
Table 29. Global Mirabegron Sustained Release Tablets Sales Market Share by Type (2020-2025)
Table 30. Global Mirabegron Sustained Release Tablets Market Size (M USD) by Type (2020-2025)
Table 31. Global Mirabegron Sustained Release Tablets Market Share by Type (2020-2025)
Table 32. Global Mirabegron Sustained Release Tablets Price (USD/KG) by Type (2020-2025)
Table 33. Global Mirabegron Sustained Release Tablets Sales (K MT) by Application
Table 34. Global Mirabegron Sustained Release Tablets Market Size by Application
Table 35. Global Mirabegron Sustained Release Tablets Sales by Application (2020-2025) & (K MT)
Table 36. Global Mirabegron Sustained Release Tablets Sales Market Share by Application (2020-2025)
Table 37. Global Mirabegron Sustained Release Tablets Market Size by Application (2020-2025) & (M USD)
Table 38. Global Mirabegron Sustained Release Tablets Market Share by Application (2020-2025)
Table 39. Global Mirabegron Sustained Release Tablets Sales Growth Rate by Application (2020-2025)
Table 40. Global Mirabegron Sustained Release Tablets Sales by Region (2020-2025) & (K MT)
Table 41. Global Mirabegron Sustained Release Tablets Sales Market Share by Region (2020-2025)
Table 42. Global Mirabegron Sustained Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 43. Global Mirabegron Sustained Release Tablets Market Size by Region (2020-2025)
Table 44. North America Mirabegron Sustained Release Tablets Sales by Country (2020-2025) & (K MT)
Table 45. North America Mirabegron Sustained Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Mirabegron Sustained Release Tablets Sales by Country (2020-2025) & (K MT)
Table 47. Europe Mirabegron Sustained Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Mirabegron Sustained Release Tablets Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Mirabegron Sustained Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 50. South America Mirabegron Sustained Release Tablets Sales by Country (2020-2025) & (K MT)
Table 51. South America Mirabegron Sustained Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Mirabegron Sustained Release Tablets Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Mirabegron Sustained Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 54. Global Mirabegron Sustained Release Tablets Production (K MT) by Region(2020-2025)
Table 55. Global Mirabegron Sustained Release Tablets Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Mirabegron Sustained Release Tablets Revenue Market Share by Region (2020-2025)
Table 57. Global Mirabegron Sustained Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Mirabegron Sustained Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Mirabegron Sustained Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Mirabegron Sustained Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Mirabegron Sustained Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Astellas Pharma Basic Information
Table 63. Astellas Pharma Mirabegron Sustained Release Tablets Product Overview
Table 64. Astellas Pharma Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Astellas Pharma Business Overview
Table 66. Astellas Pharma SWOT Analysis
Table 67. Astellas Pharma Recent Developments
Table 68. Zydus Lifesciences Basic Information
Table 69. Zydus Lifesciences Mirabegron Sustained Release Tablets Product Overview
Table 70. Zydus Lifesciences Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Zydus Lifesciences Business Overview
Table 72. Zydus Lifesciences SWOT Analysis
Table 73. Zydus Lifesciences Recent Developments
Table 74. Lupin Pharmaceuticals Basic Information
Table 75. Lupin Pharmaceuticals Mirabegron Sustained Release Tablets Product Overview
Table 76. Lupin Pharmaceuticals Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Lupin Pharmaceuticals Business Overview
Table 78. Lupin Pharmaceuticals SWOT Analysis
Table 79. Lupin Pharmaceuticals Recent Developments
Table 80. Alkem Laboratories Basic Information
Table 81. Alkem Laboratories Mirabegron Sustained Release Tablets Product Overview
Table 82. Alkem Laboratories Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Alkem Laboratories Business Overview
Table 84. Alkem Laboratories Recent Developments
Table 85. Chia Tai Tianqing Pharmaceutical Basic Information
Table 86. Chia Tai Tianqing Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 87. Chia Tai Tianqing Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Chia Tai Tianqing Pharmaceutical Business Overview
Table 89. Chia Tai Tianqing Pharmaceutical Recent Developments
Table 90. Zhejiang Huayi Pharmaceutical Basic Information
Table 91. Zhejiang Huayi Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 92. Zhejiang Huayi Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Zhejiang Huayi Pharmaceutical Business Overview
Table 94. Zhejiang Huayi Pharmaceutical Recent Developments
Table 95. China Resources Pharmaceutical Basic Information
Table 96. China Resources Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 97. China Resources Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. China Resources Pharmaceutical Business Overview
Table 99. China Resources Pharmaceutical Recent Developments
Table 100. Jiangxi Shanxiang Pharmaceutical Basic Information
Table 101. Jiangxi Shanxiang Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 102. Jiangxi Shanxiang Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Jiangxi Shanxiang Pharmaceutical Business Overview
Table 104. Jiangxi Shanxiang Pharmaceutical Recent Developments
Table 105. CSPC Pharmaceutical Basic Information
Table 106. CSPC Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 107. CSPC Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. CSPC Pharmaceutical Business Overview
Table 109. CSPC Pharmaceutical Recent Developments
Table 110. Qilu Pharmaceutical Basic Information
Table 111. Qilu Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 112. Qilu Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Qilu Pharmaceutical Business Overview
Table 114. Qilu Pharmaceutical Recent Developments
Table 115. Jiangsu Huayang Pharmaceutical Basic Information
Table 116. Jiangsu Huayang Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 117. Jiangsu Huayang Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Jiangsu Huayang Pharmaceutical Business Overview
Table 119. Jiangsu Huayang Pharmaceutical Recent Developments
Table 120. Sichuan Gowell Pharmaceutical Basic Information
Table 121. Sichuan Gowell Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 122. Sichuan Gowell Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Sichuan Gowell Pharmaceutical Business Overview
Table 124. Sichuan Gowell Pharmaceutical Recent Developments
Table 125. Shenzhen Main Luck Pharmaceuticals Basic Information
Table 126. Shenzhen Main Luck Pharmaceuticals Mirabegron Sustained Release Tablets Product Overview
Table 127. Shenzhen Main Luck Pharmaceuticals Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Shenzhen Main Luck Pharmaceuticals Business Overview
Table 129. Shenzhen Main Luck Pharmaceuticals Recent Developments
Table 130. Global Mirabegron Sustained Release Tablets Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global Mirabegron Sustained Release Tablets Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Mirabegron Sustained Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America Mirabegron Sustained Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Mirabegron Sustained Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe Mirabegron Sustained Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Mirabegron Sustained Release Tablets Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific Mirabegron Sustained Release Tablets Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Mirabegron Sustained Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America Mirabegron Sustained Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Mirabegron Sustained Release Tablets Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Mirabegron Sustained Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Mirabegron Sustained Release Tablets Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global Mirabegron Sustained Release Tablets Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Mirabegron Sustained Release Tablets Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global Mirabegron Sustained Release Tablets Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global Mirabegron Sustained Release Tablets Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Mirabegron Sustained Release Tablets Market Size by Type (M USD)
Table 4. Global Mirabegron Sustained Release Tablets Market Size by Application
Table 5. Mirabegron Sustained Release Tablets Market Size Comparison by Region (M USD)
Table 6. Global Mirabegron Sustained Release Tablets Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Mirabegron Sustained Release Tablets Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Mirabegron Sustained Release Tablets Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Mirabegron Sustained Release Tablets Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mirabegron Sustained Release Tablets as of 2025)
Table 11. Global Market Mirabegron Sustained Release Tablets Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Mirabegron Sustained Release Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Mirabegron Sustained Release Tablets Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Mirabegron Sustained Release Tablets Sales by Type (K MT)
Table 27. Global Mirabegron Sustained Release Tablets Market Size by Type (M USD)
Table 28. Global Mirabegron Sustained Release Tablets Sales (K MT) by Type (2020-2025)
Table 29. Global Mirabegron Sustained Release Tablets Sales Market Share by Type (2020-2025)
Table 30. Global Mirabegron Sustained Release Tablets Market Size (M USD) by Type (2020-2025)
Table 31. Global Mirabegron Sustained Release Tablets Market Share by Type (2020-2025)
Table 32. Global Mirabegron Sustained Release Tablets Price (USD/KG) by Type (2020-2025)
Table 33. Global Mirabegron Sustained Release Tablets Sales (K MT) by Application
Table 34. Global Mirabegron Sustained Release Tablets Market Size by Application
Table 35. Global Mirabegron Sustained Release Tablets Sales by Application (2020-2025) & (K MT)
Table 36. Global Mirabegron Sustained Release Tablets Sales Market Share by Application (2020-2025)
Table 37. Global Mirabegron Sustained Release Tablets Market Size by Application (2020-2025) & (M USD)
Table 38. Global Mirabegron Sustained Release Tablets Market Share by Application (2020-2025)
Table 39. Global Mirabegron Sustained Release Tablets Sales Growth Rate by Application (2020-2025)
Table 40. Global Mirabegron Sustained Release Tablets Sales by Region (2020-2025) & (K MT)
Table 41. Global Mirabegron Sustained Release Tablets Sales Market Share by Region (2020-2025)
Table 42. Global Mirabegron Sustained Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 43. Global Mirabegron Sustained Release Tablets Market Size by Region (2020-2025)
Table 44. North America Mirabegron Sustained Release Tablets Sales by Country (2020-2025) & (K MT)
Table 45. North America Mirabegron Sustained Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Mirabegron Sustained Release Tablets Sales by Country (2020-2025) & (K MT)
Table 47. Europe Mirabegron Sustained Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Mirabegron Sustained Release Tablets Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Mirabegron Sustained Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 50. South America Mirabegron Sustained Release Tablets Sales by Country (2020-2025) & (K MT)
Table 51. South America Mirabegron Sustained Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Mirabegron Sustained Release Tablets Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Mirabegron Sustained Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 54. Global Mirabegron Sustained Release Tablets Production (K MT) by Region(2020-2025)
Table 55. Global Mirabegron Sustained Release Tablets Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Mirabegron Sustained Release Tablets Revenue Market Share by Region (2020-2025)
Table 57. Global Mirabegron Sustained Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Mirabegron Sustained Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Mirabegron Sustained Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Mirabegron Sustained Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Mirabegron Sustained Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Astellas Pharma Basic Information
Table 63. Astellas Pharma Mirabegron Sustained Release Tablets Product Overview
Table 64. Astellas Pharma Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Astellas Pharma Business Overview
Table 66. Astellas Pharma SWOT Analysis
Table 67. Astellas Pharma Recent Developments
Table 68. Zydus Lifesciences Basic Information
Table 69. Zydus Lifesciences Mirabegron Sustained Release Tablets Product Overview
Table 70. Zydus Lifesciences Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Zydus Lifesciences Business Overview
Table 72. Zydus Lifesciences SWOT Analysis
Table 73. Zydus Lifesciences Recent Developments
Table 74. Lupin Pharmaceuticals Basic Information
Table 75. Lupin Pharmaceuticals Mirabegron Sustained Release Tablets Product Overview
Table 76. Lupin Pharmaceuticals Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Lupin Pharmaceuticals Business Overview
Table 78. Lupin Pharmaceuticals SWOT Analysis
Table 79. Lupin Pharmaceuticals Recent Developments
Table 80. Alkem Laboratories Basic Information
Table 81. Alkem Laboratories Mirabegron Sustained Release Tablets Product Overview
Table 82. Alkem Laboratories Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Alkem Laboratories Business Overview
Table 84. Alkem Laboratories Recent Developments
Table 85. Chia Tai Tianqing Pharmaceutical Basic Information
Table 86. Chia Tai Tianqing Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 87. Chia Tai Tianqing Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Chia Tai Tianqing Pharmaceutical Business Overview
Table 89. Chia Tai Tianqing Pharmaceutical Recent Developments
Table 90. Zhejiang Huayi Pharmaceutical Basic Information
Table 91. Zhejiang Huayi Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 92. Zhejiang Huayi Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Zhejiang Huayi Pharmaceutical Business Overview
Table 94. Zhejiang Huayi Pharmaceutical Recent Developments
Table 95. China Resources Pharmaceutical Basic Information
Table 96. China Resources Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 97. China Resources Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. China Resources Pharmaceutical Business Overview
Table 99. China Resources Pharmaceutical Recent Developments
Table 100. Jiangxi Shanxiang Pharmaceutical Basic Information
Table 101. Jiangxi Shanxiang Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 102. Jiangxi Shanxiang Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Jiangxi Shanxiang Pharmaceutical Business Overview
Table 104. Jiangxi Shanxiang Pharmaceutical Recent Developments
Table 105. CSPC Pharmaceutical Basic Information
Table 106. CSPC Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 107. CSPC Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. CSPC Pharmaceutical Business Overview
Table 109. CSPC Pharmaceutical Recent Developments
Table 110. Qilu Pharmaceutical Basic Information
Table 111. Qilu Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 112. Qilu Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Qilu Pharmaceutical Business Overview
Table 114. Qilu Pharmaceutical Recent Developments
Table 115. Jiangsu Huayang Pharmaceutical Basic Information
Table 116. Jiangsu Huayang Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 117. Jiangsu Huayang Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Jiangsu Huayang Pharmaceutical Business Overview
Table 119. Jiangsu Huayang Pharmaceutical Recent Developments
Table 120. Sichuan Gowell Pharmaceutical Basic Information
Table 121. Sichuan Gowell Pharmaceutical Mirabegron Sustained Release Tablets Product Overview
Table 122. Sichuan Gowell Pharmaceutical Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Sichuan Gowell Pharmaceutical Business Overview
Table 124. Sichuan Gowell Pharmaceutical Recent Developments
Table 125. Shenzhen Main Luck Pharmaceuticals Basic Information
Table 126. Shenzhen Main Luck Pharmaceuticals Mirabegron Sustained Release Tablets Product Overview
Table 127. Shenzhen Main Luck Pharmaceuticals Mirabegron Sustained Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Shenzhen Main Luck Pharmaceuticals Business Overview
Table 129. Shenzhen Main Luck Pharmaceuticals Recent Developments
Table 130. Global Mirabegron Sustained Release Tablets Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global Mirabegron Sustained Release Tablets Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Mirabegron Sustained Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America Mirabegron Sustained Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Mirabegron Sustained Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe Mirabegron Sustained Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Mirabegron Sustained Release Tablets Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific Mirabegron Sustained Release Tablets Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Mirabegron Sustained Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America Mirabegron Sustained Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Mirabegron Sustained Release Tablets Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Mirabegron Sustained Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Mirabegron Sustained Release Tablets Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global Mirabegron Sustained Release Tablets Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Mirabegron Sustained Release Tablets Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global Mirabegron Sustained Release Tablets Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global Mirabegron Sustained Release Tablets Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Mirabegron Sustained Release Tablets
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Mirabegron Sustained Release Tablets Market Size (M USD), 2025-2035
Figure 5. Global Mirabegron Sustained Release Tablets Market Size (M USD) (2020-2035)
Figure 6. Global Mirabegron Sustained Release Tablets Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Mirabegron Sustained Release Tablets Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Mirabegron Sustained Release Tablets Product Life Cycle
Figure 13. Mirabegron Sustained Release Tablets Sales Share by Manufacturers in 2025
Figure 14. Global Mirabegron Sustained Release Tablets Revenue Share by Manufacturers in 2025
Figure 15. Mirabegron Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Mirabegron Sustained Release Tablets Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Mirabegron Sustained Release Tablets Revenue in 2025
Figure 18. Industry Chain Map of Mirabegron Sustained Release Tablets
Figure 19. Global Mirabegron Sustained Release Tablets Market PEST Analysis
Figure 20. Global Mirabegron Sustained Release Tablets Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Mirabegron Sustained Release Tablets Market Share by Type
Figure 27. Sales Market Share of Mirabegron Sustained Release Tablets by Type (2020-2025)
Figure 28. Sales Market Share of Mirabegron Sustained Release Tablets by Type in 2025
Figure 29. Market Share of Mirabegron Sustained Release Tablets by Type (2020-2025)
Figure 30. Market Share of Mirabegron Sustained Release Tablets by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Mirabegron Sustained Release Tablets Market Share by Application
Figure 33. Global Mirabegron Sustained Release Tablets Sales Market Share by Application (2020-2025)
Figure 34. Global Mirabegron Sustained Release Tablets Sales Market Share by Application in 2025
Figure 35. Global Mirabegron Sustained Release Tablets Market Share by Application (2020-2025)
Figure 36. Global Mirabegron Sustained Release Tablets Market Share by Application in 2025
Figure 37. Global Mirabegron Sustained Release Tablets Sales Growth Rate by Application (2020-2025)
Figure 38. Global Mirabegron Sustained Release Tablets Sales Market Share by Region (2020-2025)
Figure 39. Global Mirabegron Sustained Release Tablets Market Size by Region (2020-2025)
Figure 40. North America Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Mirabegron Sustained Release Tablets Sales Market Share by Country in 2024
Figure 43. North America Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Mirabegron Sustained Release Tablets Market Size by Country in 2024
Figure 45. U.S. Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Mirabegron Sustained Release Tablets Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Mirabegron Sustained Release Tablets Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Mirabegron Sustained Release Tablets Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Mirabegron Sustained Release Tablets Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Mirabegron Sustained Release Tablets Sales Market Share by Country in 2024
Figure 53. Europe Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Mirabegron Sustained Release Tablets Market Size by Country in 2024
Figure 55. Germany Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Mirabegron Sustained Release Tablets Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Mirabegron Sustained Release Tablets Sales Market Share by Region in 2024
Figure 67. Asia Pacific Mirabegron Sustained Release Tablets Market Size by Region in 2024
Figure 68. China Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Mirabegron Sustained Release Tablets Sales and Growth Rate (K MT)
Figure 79. South America Mirabegron Sustained Release Tablets Sales Market Share by Country in 2024
Figure 80. South America Mirabegron Sustained Release Tablets Market Size and Growth Rate (M USD)
Figure 81. South America Mirabegron Sustained Release Tablets Market Size by Country in 2024
Figure 82. Brazil Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Mirabegron Sustained Release Tablets Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Mirabegron Sustained Release Tablets Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Mirabegron Sustained Release Tablets Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Mirabegron Sustained Release Tablets Market Size by Region in 2024
Figure 92. Saudi Arabia Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Mirabegron Sustained Release Tablets Production Market Share by Region (2020-2025)
Figure 103. North America Mirabegron Sustained Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Mirabegron Sustained Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Mirabegron Sustained Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 106. China Mirabegron Sustained Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Mirabegron Sustained Release Tablets Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Mirabegron Sustained Release Tablets Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Mirabegron Sustained Release Tablets Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Mirabegron Sustained Release Tablets Market Share Forecast by Type (2026-2035)
Figure 111. Global Mirabegron Sustained Release Tablets Sales Forecast by Application (2026-2035)
Figure 112. Global Mirabegron Sustained Release Tablets Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Mirabegron Sustained Release Tablets
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Mirabegron Sustained Release Tablets Market Size (M USD), 2025-2035
Figure 5. Global Mirabegron Sustained Release Tablets Market Size (M USD) (2020-2035)
Figure 6. Global Mirabegron Sustained Release Tablets Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Mirabegron Sustained Release Tablets Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Mirabegron Sustained Release Tablets Product Life Cycle
Figure 13. Mirabegron Sustained Release Tablets Sales Share by Manufacturers in 2025
Figure 14. Global Mirabegron Sustained Release Tablets Revenue Share by Manufacturers in 2025
Figure 15. Mirabegron Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Mirabegron Sustained Release Tablets Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Mirabegron Sustained Release Tablets Revenue in 2025
Figure 18. Industry Chain Map of Mirabegron Sustained Release Tablets
Figure 19. Global Mirabegron Sustained Release Tablets Market PEST Analysis
Figure 20. Global Mirabegron Sustained Release Tablets Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Mirabegron Sustained Release Tablets Market Share by Type
Figure 27. Sales Market Share of Mirabegron Sustained Release Tablets by Type (2020-2025)
Figure 28. Sales Market Share of Mirabegron Sustained Release Tablets by Type in 2025
Figure 29. Market Share of Mirabegron Sustained Release Tablets by Type (2020-2025)
Figure 30. Market Share of Mirabegron Sustained Release Tablets by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Mirabegron Sustained Release Tablets Market Share by Application
Figure 33. Global Mirabegron Sustained Release Tablets Sales Market Share by Application (2020-2025)
Figure 34. Global Mirabegron Sustained Release Tablets Sales Market Share by Application in 2025
Figure 35. Global Mirabegron Sustained Release Tablets Market Share by Application (2020-2025)
Figure 36. Global Mirabegron Sustained Release Tablets Market Share by Application in 2025
Figure 37. Global Mirabegron Sustained Release Tablets Sales Growth Rate by Application (2020-2025)
Figure 38. Global Mirabegron Sustained Release Tablets Sales Market Share by Region (2020-2025)
Figure 39. Global Mirabegron Sustained Release Tablets Market Size by Region (2020-2025)
Figure 40. North America Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Mirabegron Sustained Release Tablets Sales Market Share by Country in 2024
Figure 43. North America Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Mirabegron Sustained Release Tablets Market Size by Country in 2024
Figure 45. U.S. Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Mirabegron Sustained Release Tablets Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Mirabegron Sustained Release Tablets Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Mirabegron Sustained Release Tablets Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Mirabegron Sustained Release Tablets Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Mirabegron Sustained Release Tablets Sales Market Share by Country in 2024
Figure 53. Europe Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Mirabegron Sustained Release Tablets Market Size by Country in 2024
Figure 55. Germany Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Mirabegron Sustained Release Tablets Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Mirabegron Sustained Release Tablets Sales Market Share by Region in 2024
Figure 67. Asia Pacific Mirabegron Sustained Release Tablets Market Size by Region in 2024
Figure 68. China Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Mirabegron Sustained Release Tablets Sales and Growth Rate (K MT)
Figure 79. South America Mirabegron Sustained Release Tablets Sales Market Share by Country in 2024
Figure 80. South America Mirabegron Sustained Release Tablets Market Size and Growth Rate (M USD)
Figure 81. South America Mirabegron Sustained Release Tablets Market Size by Country in 2024
Figure 82. Brazil Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Mirabegron Sustained Release Tablets Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Mirabegron Sustained Release Tablets Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Mirabegron Sustained Release Tablets Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Mirabegron Sustained Release Tablets Market Size by Region in 2024
Figure 92. Saudi Arabia Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Mirabegron Sustained Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Mirabegron Sustained Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Mirabegron Sustained Release Tablets Production Market Share by Region (2020-2025)
Figure 103. North America Mirabegron Sustained Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Mirabegron Sustained Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Mirabegron Sustained Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 106. China Mirabegron Sustained Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Mirabegron Sustained Release Tablets Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Mirabegron Sustained Release Tablets Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Mirabegron Sustained Release Tablets Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Mirabegron Sustained Release Tablets Market Share Forecast by Type (2026-2035)
Figure 111. Global Mirabegron Sustained Release Tablets Sales Forecast by Application (2026-2035)
Figure 112. Global Mirabegron Sustained Release Tablets Market Share Forecast by Application (2026-2035)
